Conclusion
In this article we suggest on the basis of today’s pharmacological and
molecular knowledge, that by modulating the RAS system and the delicate
ACE / ACE 2 Ang II balance in the best way and at the right times with
common treatments such as ACE-i, ARB and direct renin inhibitors we can
have important preventive and curative benefits to fight SARS-Cov-2.
MAIN STATEMENTS
I, the undersigned, Francesco Ferrara and any other author, declare
that:
We have no conflict of interest;
We have not received funding;
There are no sensitive data and no patients were recruited for this
study;
The document does not conflict with ethical legislation.
Regards